Sanara MedTech (SMTI) reported Q4 preliminary revenue late Tuesday of $25.7 million to $26.2 million, up 45% to 48% from a year earlier.
Two analysts polled by FactSet expect $22.8 million.
The company said it had cash of $15.9 million as of Dec. 31, compared with $16.3 million as of Sept. 30.
Sanara MedTech appointed Elizabeth Taylor as chief financial officer, succeeding Michael McNeil, who was named chief accounting officer and chief administrative officer.
The appointments were effective Jan. 15, the company said Tuesday in a statement.
Taylor most recently served as CFO of Imbed Biosciences.
Sanara MedTech shares rose 9.7% in recent after-hours activity.
Price: 37.28, Change: +3.28, Percent Change: +9.65
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。